| Date | Time | Source | Headline | Symbol | Company |
| 11/16/2018 | 6:18AM | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:KERX | Keryx Biopharmaceuticals, Inc. (delisted) |
| 11/16/2018 | 6:18AM | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:KERX | Keryx Biopharmaceuticals, Inc. (delisted) |
| 11/15/2018 | 5:24PM | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:KERX | Keryx Biopharmaceuticals, Inc. (delisted) |
| 11/15/2018 | 5:23PM | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:KERX | Keryx Biopharmaceuticals, Inc. (delisted) |
| 11/15/2018 | 5:15PM | Business Wire | Akebia Therapeutics and Keryx Biopharmaceuticals Announce Chairperson for Combined Company | NASDAQ:KERX | Keryx Biopharmaceuticals, Inc. (delisted) |
| 11/13/2018 | 4:09PM | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:KERX | Keryx Biopharmaceuticals, Inc. (delisted) |
| 11/13/2018 | 4:09PM | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:KERX | Keryx Biopharmaceuticals, Inc. (delisted) |
| 11/13/2018 | 6:07AM | Edgar (US Regulatory) | Amended Quarterly Report (10-q/a) | NASDAQ:KERX | Keryx Biopharmaceuticals, Inc. (delisted) |
| 11/09/2018 | 4:09PM | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:KERX | Keryx Biopharmaceuticals, Inc. (delisted) |
| 11/08/2018 | 5:32PM | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:KERX | Keryx Biopharmaceuticals, Inc. (delisted) |
| 11/08/2018 | 5:23PM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:KERX | Keryx Biopharmaceuticals, Inc. (delisted) |
| 11/08/2018 | 4:30PM | GlobeNewswire Inc. | Keryx Biopharmaceuticals Announces Third Quarter 2018 Financial Results | NASDAQ:KERX | Keryx Biopharmaceuticals, Inc. (delisted) |
| 11/06/2018 | 4:30PM | GlobeNewswire Inc. | Keryx Biopharmaceuticals to Release Third Quarter 2018 Financial Results on Thursday, November 8, 2018 | NASDAQ:KERX | Keryx Biopharmaceuticals, Inc. (delisted) |
| 10/31/2018 | 4:10PM | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:KERX | Keryx Biopharmaceuticals, Inc. (delisted) |
| 10/31/2018 | 6:15AM | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:KERX | Keryx Biopharmaceuticals, Inc. (delisted) |
| 10/30/2018 | 5:31PM | GlobeNewswire Inc. | Keryx Biopharmaceuticals Announces Filing of Definitive Joint Proxy Statement in Connection with Pending Merger with Akebia T... | NASDAQ:KERX | Keryx Biopharmaceuticals, Inc. (delisted) |
| 10/30/2018 | 5:30PM | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:KERX | Keryx Biopharmaceuticals, Inc. (delisted) |
| 10/30/2018 | 5:28PM | Edgar (US Regulatory) | Proxy Statement - Merger or Acquistion (definitive) (defm14a) | NASDAQ:KERX | Keryx Biopharmaceuticals, Inc. (delisted) |
| 10/30/2018 | 4:11PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:KERX | Keryx Biopharmaceuticals, Inc. (delisted) |
| 10/30/2018 | 4:09PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:KERX | Keryx Biopharmaceuticals, Inc. (delisted) |
| 10/29/2018 | 5:29PM | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:KERX | Keryx Biopharmaceuticals, Inc. (delisted) |
| 10/25/2018 | 5:17PM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:KERX | Keryx Biopharmaceuticals, Inc. (delisted) |
| 10/25/2018 | 5:15PM | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:KERX | Keryx Biopharmaceuticals, Inc. (delisted) |
| 10/22/2018 | 8:52AM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:KERX | Keryx Biopharmaceuticals, Inc. (delisted) |
| 10/02/2018 | 8:02AM | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:KERX | Keryx Biopharmaceuticals, Inc. (delisted) |
| 10/01/2018 | 9:16AM | GlobeNewswire Inc. | Keryx Biopharmaceuticals Announces Participation in an Upcoming Investor Conference | NASDAQ:KERX | Keryx Biopharmaceuticals, Inc. (delisted) |
| 10/01/2018 | 6:48AM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:KERX | Keryx Biopharmaceuticals, Inc. (delisted) |
| 10/01/2018 | 6:47AM | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:KERX | Keryx Biopharmaceuticals, Inc. (delisted) |
| 10/01/2018 | 6:40AM | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:KERX | Keryx Biopharmaceuticals, Inc. (delisted) |
| 09/24/2018 | 3:31PM | Edgar (US Regulatory) | Confidential Treatment Order (ct Order) | NASDAQ:KERX | Keryx Biopharmaceuticals, Inc. (delisted) |